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ABSTRACT  
 
 
We retrospectively analyzed 90 patients who in the period 1987-2003 underwent “en bloc” 
resection and modular endoprosthesis reconstruction in the lower limb.  
After proximal femur resection, reconstruction was performed with modular endoprosthesis 
(Howmedica, KFTR designed by Kotz) or with modular endoprosthesis (W.Link, Lima-Lto, designed by 
Wagner). Knee joint was reconstructed with modular endoprosthesis (Howmedica, KFTR designed by 
Kotz) after distal femur or proximal tibia resection. 
The malignant bone tumors were present in 58 patients (64.5%), benign tumors in 16 (17.8%), 
metastasis in 8 (8.9%), tumors like lesions in 4 (4.4 %), and non-tumor related destruction of femur in 
4 patients (4.4%). High grade tumors were found in the majority of malignant bone tumors (70.7%).  
Treatment complications, which occurred in 26 patients, are as follows: local recurrence of tumor, 
deep infection, acetabular destruction following hemiarthroplasty, recurrent dislocations of 
endoprosthesis, periprosthetic fracture, and hardware problem. In total, 23 patients (25.6%) died due 
to tumor. 
Endoprostheses should be considered as a treatment of choice for bone tumors in the hip and 
knee joint region. Advances in limb salvage surgery are and will be for a long time a great challenge 
for orthopaedic oncologists of the 21st century. 
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INTRODUCTION 
 
 
Limb salvage surgery, currently an accepted bone tumor treatment method, has traditionally been 
a difficult problem in orthopaedic oncology. With the development of modern chemotherapy, the 
outlook for malignant tumors has greatly improved and encouraged surgeons to consider limb salvage 
surgery in most cases. The success of limb salvage is the result of advances in the understanding of 
the biology and staging of tumors, improvement in the reconstructive techniques, and the development 
of effective adjuvant chemotherapy for the primary tumors, and is still going on [7, 18]. 
 
The appropriate treatment to achieve local control after resection of bone tumor is still a subject of 
debate, and the long-term durability of various reconstructive methods is not known. Currently, the 
three most popular options are using an endoprosthesis, allograft-prosthetic composite, and biological 
reconstructions [6, 10, 17, 21]. Each of those methods has its short- and long-term advantages and 
disadvantages, and a surgeon should consider each patient individually.  
Endoprosthetic replacement offers several advantages, such as early stability, mobilization and 
weight bearing, a shorter operating time and hospital stay in comparison to biologic reconstructions, 
and it allows early introduction of post-operative adjuvant therapy. Reconstruction with a modular 
endoprosthesis after resection of a bone tumor gives good functional results in most of the cases [14, 
22].  
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PATIENTS AND METHODS 
 
 
We retrospectively analyzed 90 patients treated by resection and reconstruction with a modular 
endoprosthesis in the lower extremity during 17 years (1987-2003) (Fig. 1). There were 39 males and 
51 females with a median age at diagnosis of 30 (7-66) years. 
 
Tumor was localized in proximal femur in 44 patients, distal femur in 30 patients, and proximal 
tibia in 16 patients. For reconstruction of the hip joint after proximal femur resection, we used modular 
endoprosthesis (Howmedica, KFTR designed by Kotz) in 26 and modular endoprosthesis (W.Link, 
Lima-Lto, designed by Wagner) in 18 patients. For knee joint reconstruction we used only modular 
endoprosthesis (Howmedica, KFTR designed by Kotz) in both distal femur and proximal tibia 
reconstruction.  
All patients were given chemotherapy and radiotherapy according to the regimen in use at the 
time. Surgical approach was performed according to the general principles of limb salvage surgery, 
and resection length was determined preoperatively by radiographic and other imaging methods. In 
total, median resection length was 15 cm (range 6-25): the longest resections were performed in distal 
femur (median 16 cm, range 12-25), followed be proximal femur (median 15 cm, range 6-25) and 
proximal tibia (median 12 cm, range 7-15). All patients received perioperative prophylactic antibiotics 
and thromboprophylaxis according to the guidelines in our hospital at the time. 
 
We analyzed data of clinical findings before primary operation, radiographic and other imaging 
methods, radioisotope bone scans, open biopsy findings, intraoperative findings and finally clinical 
results during postoperative ambulatory control examinations. All tumors were graded according to the 
Enneking system [8].  
 
The mean follow-up was 9 years (range: 3-19); 72 of 90 patients had follow-up for more than 5 
years.  
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RESULTS 
 
The malignant bone tumors were present in 58 patients (64.5%), benign tumors in 16 (17.8%), 
metastasis in 8 (8.9%), and tumors like lesions in 4 (4.4 %) patients. The most common diagnose was 
osteosarcoma in 27 patients (30%), Ewing sarcoma in 15 patients (16.7%), and giant cell tumor of 
bone in 13 patients (14.4%). 
High grade tumors (grade 2a and 2b) were found in the majority of malignant bone tumors: in 21 
of 27 (77.8%) patients with osteosarcoma, in 10 of 15 (66.7%) patients with Ewing sarcoma, and in 41 
of 58 (70.7%) of all malignant bone tumors. Active tumor grade 3 was found in the majority of patients 
with giant cell tumor of bone (in 7 of 13 (53.8%) patients). Detailed histological findings and tumor 
grades are shown in Table 1. Destruction of femur due to war wound or primary endoprosthesis 
instability, present in 4 patients, was also included in this analysis.  
We found 6 patients with pathologic fracture prior to the primary operation: in two patients with 
osteosarcoma, two patients with secondary bone tumor, one patient with Ewing sarcoma and in one 
with giant cell tumor of bone. Five of them had pathologic fracture of proximal femur, and one of distal 
femur. 
 
During treatment, 26 patients had one of the following complications: local recurrences of tumor, 
deep infection, acetabular destruction following hemiarthroplasty, recurrent dislocations of 
endoprosthesis, periprosthetic fractures, and hardware problems. Details of the complications, 
treatment methods, and final results are shown in Table 2. 
 
In 10 patients we found local recurrences of tumor, and 5 of them died. Patients who died due to 
tumor are as follows: 9 of 27 patients with osteosarcoma (33.3%), 4 of 15 patients with Ewing sarcoma 
(26.7%), 4 of 8 patients with secondary bone tumor (50%), 3 of 8 patients with chondrosarcoma 
(37.5%), one patient with fibrosarcoma, one patient with malignant fibrous histiocytoma, and one 
patient with a war wound. In total, during the follow-up period, 23 patients died due to tumor. 
At the last control examination, 65 patients showed no evidence of primary disease. Two patients 
were lost in follow-up for changing the place of living because of situation in the region. 
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DISCUSSION 
 
 
Chemotherapy has dramatically changed the cure rate of malignant bone tumors. Since the 
introduction of effective neoadjuvant chemotherapy in the 1980s, >80% of patients with osteosarcoma 
of the extremity have been considered candidates for limb-salvage surgery [2, 15]. Increasing trend in 
limb-salvage surgery - using endoprosthesis is evident also in this study (Fig. 1). 
 
More than a third of our patients (37.8%) were younger than 20, and almost half of them (47.8%) 
were under age of 25. For medical, surgical, and rehabilitative advances, limb-salvage surgery has 
surpassed amputation as the primary treatment for malignant bone tumors in young children [4, 14]. 
Preservation of limb function in the pediatric oncology patient is uniquely challenging. In skeletally 
immature patients, the functional impairment that is due to the subsequent growth inhibition must be 
considered in conjunction with limb-salvage surgery [1, 9].  
Prosthetic reconstruction in the skeletally immature patient is demanding because of the necessity 
to cope with expected disruption of limb growth after resection of one or more major growth plates and 
the high demands placed on implants by young patients. Expandable endoprosthesis have important 
place in treating still growing children, but we did not use them mainly for financial reasons. Although 
endoprosthetic reconstruction in children is fraught with many problems, it is usually possible to obtain 
a good functional limb at skeletal maturity. Treatment must be strictly prioritized in terms of the 
patient's life, the limb, its function, length equalization, and cosmetic appearance. Orthopaedic 
intervention in the care of children and young adults with oncologic conditions must be individualized 
[1, 24]. 
 
An individual approach to every patient is essential in order to choose the most suitable surgical 
treatment for pathologic fractures due to primary bone tumors, metastasis or tumor like lesions. The 
aim of surgical treatment is primary to treat/remove tumorous tissue, and than to heal fracture, 
maintain or restore function, and minimize pain thus improving the patient's quality of life [23]. 
Relatively small number of patients with secondary bone tumor in this report does not represent 
the real incidence of those tumors. Our Department has no emergency units, and only exceptionally 
we treat such patients.  
 
We used modular endoprosthesis model Wagner in treating bone tumors in proximal femur region 
mostly because of technical and financial reasons in our health system. Our Department always has 
on stock all sizes of Wagner stems for treating aseptic loosening, therefore in the case of emergency 
endoprosthesis is available immediately.  
 
Two patients with low grade tumor-like lesions were treated by resection and endoprosthesis 
reconstruction: in one patient with grade 1 aneurysmal bone cyst the reason was articular surface 
destruction, and in a patient with fibrous dysplasia lesion size was more than 2/3 of total femur length, 
and proximal femur resection size was 22 cm.  
More than two thirds of patients began the orthopaedic treatment of malignant bone tumor at the 
point when histological activity of tumor shifted to more aggressive histological grade. Malignant bone 
tumors are of major concern in orthopaedic surgery, and the beginning of the treatment should be as 
soon as possible. Losing precious time, these patients come late to a specialist of orthopaedic 
oncology, what is a sign of inefficiency of our health system. Education of general physicians, 
physicians of other specialties, and general population should also be in domain of orthopaedic 
oncologist. 
 
The most common complication in treating our patients was local recurrence of tumor. That data 
should be analyzed together with information of tumor grade. Majority of the patients with malignant 
bone tumor had high grade tumor, what made the treatment more complicated. After local recurrence 
of tumor (in 10 patients), radical surgical treatment resulted in saving half of those patients, who are 
now disease-free. 
 
Deep infection was the second most common complication, occurred in 5 patients in our study. In 
the previous literature, the rate of deep infection has ranged from 4 to more than 30% [5, 11]. 
Curettage, débridement and irrigation were performed in 3 patients, and in 2 patients we had 
unsatisfactory final results: amputation following local recurrence in one patient, and knee ankylosis in 
other patient. Staged reimplantation was performed in 1 patient, and 1 patient with tumoral 
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endoprosthesis implantation for a war wound (because of psychical condition - PTSD) refused 
treatment.  
 
Dislocation is the most common complication after primary or secondary femur endoprosthetic 
reconstruction, regardless the indication. There is still no widely accepted method which helps 
avoiding this complication. In the orthopaedic literature the rate of hip dislocation following 
reconstruction of proximal femoral tumors with megaprosthesis varies from 2 to 28% [3]. In general, 
the main reasons for dislocated hips are extensive soft tissue resection due to the large size of the 
tumor. Our study, expectedly, showed that 4 of 44 (9.1%) patients had hip dislocation. We managed to 
perform closed reposition and applied the hip brace in all 4 of our patients for 4-6 weeks.  
 
Reconstruction of femur after tumor resection was performed by hemiarthroplasty in 4 children. 
Growing acetabular bone and the selection of proper size of endoprosthetic head for achieving 
congruence would give satisfactory limb function during the time after operation. The main problem 
occurs after a few years because of the physiological enlargement of the acetabular diameter: 
incongruency between the endoprosthetic head and the acetabulum results in alternation of pressure 
on acetabulum and lateral migration of endoprosthesis head, what finally leads to destruction of 
acetabulum roof and subluxation of the endoprosthetic head. 
Acetabuloplasty with total hip endoprosthesis in growing children will cause epiphysiodesis and 
restrain acetabular growth: that procedure is performed mostly on older children and adults. In 
younger - still growing children, in case of proximal migration of the prosthesis in hemiarthroplasty, for 
salvage procedure an acetabuloplasty with bone homotransplant and implantation of greater diameter 
femoral endoprosthetic head can be performed. The goal is to allow acetabulum to grow as normal as 
possible and as long as possible. The acetabuloplasty with endoprosthesis was the final step of the 
acetabular reconstruction in all of our 4 young patients (Fig. 2) [20]. 
 
Periprosthetic fracture occurred in 2 patients: after car accident in one, and during sport activity in 
the other patient. Good functional status after surgery encourages the patient to go “beyond limits” of 
the operated limb. If there is no primary disease, treatment of such patients should not be a difficult 
problem (Fig. 3). 
 
Poor design of “bearing polyethylene shift” part of knee modular endoprosthesis (Howmedica, 
KFTR designed by Kotz) resulted in early wasting of that component. That model of endoprosthesis 
was implanted in one patient with GCT, and we performed 4 reoperations in order to change bearing 
polyethylene shift and solve related technical problems. Later models of the endoprosthesis removed 
that hardware problem [19]. 
 
Many studies were performed to investigate endoprosthetic survival rates after tumor resection, 
but the results cannot be summarized and systematic review cannot be performed, mostly because of 
a small number of patients, as well as different models and principles of endoprosthesis. Tumor 
endoprosthetic survival rates are mostly about 60% to 80% at five years, and 40-70% at ten years [12, 
13, 16]. Specific long-term consequences of endoprosthetic reconstructions after tumor resection for 
the patient's affected limb are still unknown [12]. In our opinion, endoprostheses should be considered 
as a treatment of choice for bone tumors in the hip and knee joint region. Advances in limb salvage 
surgery are and will be for a long time a great challenge for orthopaedic oncologists of the 21st 
century. 
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LEGENDS 
 
 
 
 
Figure 1.  
Distribution of patients according to year of resection and endoprosthesis implantation.  
 
 
 
 
 
Figure 2. 
A. Hemiarthroplasty after the “en bloc” resection of Ewing sarcoma localized in proximal femoral part. 
Patient at the age of 7. B. Subluxation of the endoprosthetic head (39 months after primary operation). 
C. Acetabuloplasty of the lateral roof with bone homotransplant, implantation of greater diameter 
endoprosthetic head (41 months after primary operation). D. Again subluxation of the endoprosthetic 
head (72 months after primary operation). E. Implantation of metal backed uncemented acetabular 
part of endoprosthesis (73 months after primary operation). 
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Figure 3.  
A. A patient with osteosarcoma localized in distal femur. B. Implantation of knee modular 
endoprosthesis (Howmedica, KFTR designed by Kotz) after the “en bloc” resection of tumor. C. 
Periprosthetic fracture of the femur, occurred during car accident 10 years after primary operation, 
treated with (D) endoprosthesis elongation. 
 
 
A B 
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Table 1. 
Number of patients according to histological type and tumor grade. 
 
 
 
Tumor type  
 
   Total # 
 
 
Benign bone tumors 
 
 grade 1 grade 2 grade 3   
Giant cell tumor of bone 1 5 7  13 
Chondroma  1 1  2 
Fibroma  1   1 
Total 1 7 8  16 
 
 
Primary bone tumors 
 
 
 grade 1a grade 1b grade 2a grade 2b  
Osteosarcoma 3 3 10 11 27 
Ewing sarcoma 3 2 2 8 15 
Chondrosarcoma  3 1 4 8 
Periosteal osteosarcoma  1   1 
Fibrosarcoma    2 2 
Plasmocytoma 1    1 
Synoviosarcoma   1  1 
Malignant fibrous histiocytoma    1 1 
Leiomyosarcoma    1 1 
Angiosarcoma  1   1 
Total 7 10 14 27 58 
 
 
Tumor-like lesions 
 
 
 grade 1 grade 2 grade 3   
Aneurysmal bone cyst 1  2  3 
Fibrous dysplasia  1   1 
Total 1 1 2  4 
 
 
Metastatic bone tumor 
 
 
Total     8 
 
 
Other 
 
 
War wound     2 
Instability of endoprosthesis     2 
Total     4 
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Table 2. 
Complications of treatment. Number in brackets represents a number of patients. Legend: DOD - died 
of disease; NED - no evidence of disease; EP - endoprosthesis 
 
 
 
Complication Diagnose Treatment Final result 
Osteosarcoma (7) Re-resection (2) 
Amputation (4) 
No therapy (1) 
DOD (4) 
NED (3) 
Chondrosarcoma (2) No therapy (1) 
Re-resection (1) 
DOD (1) 
NED (1) 
Local recurrence (10) 
Periosteal osteosarcoma (1) Re-resection (1) NED (1) 
Curettage (2) Local recurrence, 
amputation, DOD (1) 
Knee ankylosis, NED 
(1) 
Osteosarcoma (3) 
Extraction of EP, 
rearthroplasty (1) 
NED (1) 
GCT (1) Curretage (1) NED (1) 
Infections (5)  
War injury (1) Refusing treatment (1) NED (1) 
Acetabular destruction 
(4) 
Ewing sarcoma (3) 
Aneurismal bone cyst (1) 
Transformation partial 
to total EP (4) 
DOD (1) 
NED (3) 
Dislocation of hip EP 
(4) 
Osteosarcoma (1) 
Chondrosarcoma (1) 
Malignant fibrous 
histiocytoma (1) 
Metastasis (1) 
Closed reposition (4) DOD (1) 
NED (3) 
Osteosarcoma (1) Elongatio of EP (1) NED (1) Periprosthetic fractures 
(2) GCT (1) Osteosynthesis (1) NED (1) 
Technical problems 
with EP (1) 
GCT (1) 4 reoperations (1) NED (1) 
 
